Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Stomach Neoplasms 3Gastrointestinal Neoplasms 2Carcinoma, Hepatocellular 2Barrett Esophagus 2Adenocarcinoma Of Esophagus 2Stomach Ulcer 1Lymphoma, Mantle-Cell 1Gastrointestinal Hemorrhage 1Gastrointestinal Diseases 1Gastroesophageal Reflux 1Gastritis 1Fibrosis 1Colorectal Neoplasms 1Cholangiocarcinoma 1Adenomatous Polyposis Coli 1

Interventions

Specimen Handling 4Endoscopy 3Biopsy 3Itraconazole 2Endoscopy, Digestive System 2Diagnostic Imaging 2plecanatide 1obeticholic acid 1linaclotide 1Spectrum Analysis 1Sampling Studies 1Risk Assessment 1Radiofrequency Ablation 1Mass Screening 1Hematologic Tests 1Gastroscopy 1Endoscopic Mucosal Resection 1Cryosurgery 1Cetuximab 1Breath Tests 1Bevacizumab 1Aspirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Barrett Esophagus × Endoscopy, Digestive System × 1 year × Clear all
NCT04939051 2026-05-13

Obeticholic Acid for Prevention in Barrett's Esophagus

National Cancer Institute (NCI)

Phase 2 Recruiting
30 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Barrett Esophagus

NCT05107219 2026-04-07

GCC Agonist Signal in the Small Intestine

University of Wisconsin, Madison

Phase 1 Completed
43 enrolled
Gastrointestinal

Barrett Esophagus, Gastroesophageal Reflux, Gastrointestinal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡